Izana Bioscience Ltd.
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Subsidiary
- Established
- 2017-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.izanabio.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Efficacy and Safety of Namilumab for Moderate-to-severe Axial Spondyloarthritis
Phase 2
Completed
- Conditions
- Axial Spondyloarthritis
- First Posted Date
- 2018-08-09
- Last Posted Date
- 2022-03-08
- Lead Sponsor
- Izana Bioscience Ltd.
- Target Recruit Count
- 42
- Registration Number
- NCT03622658
- Locations
- 🇬🇧
Royal United Hospitals Bath, Bath, United Kingdom
🇬🇧University Hospital Birmingham, Birmingham, United Kingdom
🇬🇧University Hospital Coventry and Warwickshire, Coventry, United Kingdom
News
No news found